Premium
The Biosynthetic Gene Cluster of Pyrazomycin—A C‐Nucleoside Antibiotic with a Rare Pyrazole Moiety
Author(s) -
Zhao Guiyun,
Yao Shunyu,
Rothchild Kristina W.,
Liu Tengfei,
Liu Yu,
Lian Jiazhang,
He HaiYan,
Ryan Katherine S.,
Du YiLing
Publication year - 2020
Publication title -
chembiochem
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.05
H-Index - 126
eISSN - 1439-7633
pISSN - 1439-4227
DOI - 10.1002/cbic.201900449
Subject(s) - pyrazole , stereochemistry , biosynthesis , gene cluster , moiety , chemistry , nucleoside , enzyme , biochemistry , gene , biology
Pyrazomycin is a rare C ‐nucleoside antibiotic containing a naturally occurring pyrazole ring, the biosynthetic origin of which has remained obscure for decades. In this study we report the identification of the gene cluster responsible for pyrazomycin biosynthesis in Streptomyces candidus NRRL 3601, revealing that the StrR‐family regulator PyrR is the cluster‐situated transcriptional activator governing pyrazomycin biosynthesis. Furthermore, our results from in vivo reconstitution and stable‐isotope feeding experiments provide support for the hypothesis that PyrN is a new nitrogen–nitrogen bond‐forming enzyme that catalyzes the linkage of the ϵ‐NH 2 nitrogen atom of l ‐ N 6 ‐OH‐lysine and the α‐NH 2 nitrogen atom of l ‐glutamic acid. This study lays the foundation for further genetic and biochemical characterization of pyrazomycin pathway enzymes involved in constructing the characteristic pyrazole ring.